Research Article
Comparison of Febuxostat and Allopurinol in the Treatment of Patients with Chronic Kidney Disease Stage 3∼5 with Hyperuricemia
Table 4
Comparison of the incidence of adverse reactions between the two groups after treatment [n (%)].
| Group | n | Rash | Abnormal liver function | Gastrointestinal functional response | Allergic vasculitis | The incidence of adverse reactions |
| Control group | 50 | 2 | 4 | 3 | 2 | 11 (22.00) | Experimental group | 50 | 1 | 1 | 2 | 1 | 5 (10.00) | t value | — | — | — | — | — | 5.31 | value | — | — | — | — | — | < 0.05 |
|
|